Ivan Matić elected as EMBO Member
Recognition for outstanding achievements in the life sciences
The European Molecular Biology Organization (EMBO) elected Ivan Matić, research group leader at the Max Planck Institute for Biology of Ageing, as a new member. In total 120 researchers were appointed as new members.
Matić's research group studies protein modifications, small dynamic and reversible marks that can be added to proteins to change their function. He is particularly interested in ADP-ribosylation, a challenging modification that plays crucial roles in many physiological and pathological processes, from the response to DNA damage and cancer to neurological disorders and ageing. His group discovered serine ADP-ribosylation as a new type of histone modification and transformed this fundamental discovery into a foundational technology.
“It is a great honor for me to have been elected as an EMBO member and to join this community of outstanding scientists. I am grateful for EMBO’s support throughout my career, from being an EMBO short-term fellow to an EMBO Young Investigator. I am particularly thrilled to bring the rapidly evolving field of ADP-ribosylation to the attention of the broader life science community.”, comments Matić.
About Ivan Matić
Ivan Matić obtained his PhD in Biochemistry under the supervision of Matthias Mann at the Max Planck Institute for Biochemistry in Martinsried, Germany. After his stay as a Sir Henry Wellcome Postdoctoral Fellow with Ron Hay at the University of Dundee, Scotland he was appointed as Research Group Leader at the Max Planck Institute for Biology of Ageing and CECAD in 2014. In 2018 he was selected as an EMBO Young Investigator, and the following year, he secured an ERC consolidator grant. Matić is also the head of the Proteomics Core Facility at the Max Planck Institute for Biology of Ageing.
About EMBO
EMBO Members and Associate Members are more than 2000 researchers in Europe and around the world. New EMBO Members are elected annually. Election of EMBO Membership is recognition of research excellence and the outstanding achievements made by a life scientist.
